Correlation Between C4 Therapeutics and Oric Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both C4 Therapeutics and Oric Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining C4 Therapeutics and Oric Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between C4 Therapeutics and Oric Pharmaceuticals, you can compare the effects of market volatilities on C4 Therapeutics and Oric Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in C4 Therapeutics with a short position of Oric Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of C4 Therapeutics and Oric Pharmaceuticals.
Diversification Opportunities for C4 Therapeutics and Oric Pharmaceuticals
0.19 | Correlation Coefficient |
Average diversification
The 3 months correlation between CCCC and Oric is 0.19. Overlapping area represents the amount of risk that can be diversified away by holding C4 Therapeutics and Oric Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Oric Pharmaceuticals and C4 Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on C4 Therapeutics are associated (or correlated) with Oric Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Oric Pharmaceuticals has no effect on the direction of C4 Therapeutics i.e., C4 Therapeutics and Oric Pharmaceuticals go up and down completely randomly.
Pair Corralation between C4 Therapeutics and Oric Pharmaceuticals
Given the investment horizon of 90 days C4 Therapeutics is expected to under-perform the Oric Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, C4 Therapeutics is 1.56 times less risky than Oric Pharmaceuticals. The stock trades about -0.04 of its potential returns per unit of risk. The Oric Pharmaceuticals is currently generating about 0.2 of returns per unit of risk over similar time horizon. If you would invest 826.00 in Oric Pharmaceuticals on November 3, 2024 and sell it today you would earn a total of 216.00 from holding Oric Pharmaceuticals or generate 26.15% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
C4 Therapeutics vs. Oric Pharmaceuticals
Performance |
| Timeline |
| C4 Therapeutics |
| Oric Pharmaceuticals |
C4 Therapeutics and Oric Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with C4 Therapeutics and Oric Pharmaceuticals
The main advantage of trading using opposite C4 Therapeutics and Oric Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if C4 Therapeutics position performs unexpectedly, Oric Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oric Pharmaceuticals will offset losses from the drop in Oric Pharmaceuticals' long position.| C4 Therapeutics vs. Shattuck Labs | C4 Therapeutics vs. Prelude Therapeutics | C4 Therapeutics vs. Monte Rosa Therapeutics | C4 Therapeutics vs. Foghorn Therapeutics |
| Oric Pharmaceuticals vs. Seer Inc | Oric Pharmaceuticals vs. Anebulo Pharmaceuticals | Oric Pharmaceuticals vs. Cullinan Oncology LLC | Oric Pharmaceuticals vs. C4 Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Complementary Tools
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |